| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8557198P | 1998-05-15 | 1998-05-15 | |
| PCT/IB1999/000968WO1999059571A1 (en) | 1998-05-15 | 1999-05-14 | Use of amyloid inhibitors for modulating neuronal cell death |
| Publication Number | Publication Date |
|---|---|
| IL139688A0true IL139688A0 (en) | 2002-02-10 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13968899AIL139688A0 (en) | 1998-05-15 | 1999-05-14 | Use of amyloid inhibitors for modulating neuronal cell death |
| Country | Link |
|---|---|
| EP (1) | EP1077690A1 (en) |
| JP (1) | JP2002515429A (en) |
| AU (1) | AU3726299A (en) |
| CA (1) | CA2333203A1 (en) |
| IL (1) | IL139688A0 (en) |
| MX (1) | MXPA00011213A (en) |
| WO (1) | WO1999059571A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1609467A1 (en)* | 1998-07-28 | 2005-12-28 | Neurochem (International) Limited | Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions |
| US6670399B2 (en) | 1999-12-23 | 2003-12-30 | Neurochem (International) Limited | Compounds and methods for modulating cerebral amyloid angiopathy |
| CN100571701C (en)* | 2002-12-24 | 2009-12-23 | 贝卢斯健康(国际）有限公司 | Therapeutic articles for treating beta amyloid related diseases |
| MXPA05006940A (en)* | 2002-12-24 | 2006-02-22 | Neurochem Int Ltd | Therapeutic formulations for the treatment of beta-amyloid related diseases. |
| DE10303974A1 (en) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
| US20050142191A1 (en)* | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| AU2004251717B2 (en)* | 2003-06-23 | 2010-03-11 | Bellus Health (International) Limited | Treatment of amyloid- and epileptogenesis-associated diseases |
| EP1954718B1 (en) | 2005-11-30 | 2014-09-03 | AbbVie Inc. | Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies |
| US8497072B2 (en) | 2005-11-30 | 2013-07-30 | Abbott Laboratories | Amyloid-beta globulomer antibodies |
| SI2089417T1 (en) | 2006-10-12 | 2015-04-30 | Bhi Limited Partnership | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US20100204230A1 (en) | 2007-02-12 | 2010-08-12 | Peter Blurton | Piperazine derivatives for treatment of ad and related conditions |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| SI2238166T1 (en) | 2007-10-05 | 2014-03-31 | Genentech, Inc. | Use of anti-amyloid beta antibody in ocular diseases |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| CA2806909C (en) | 2010-07-30 | 2019-12-17 | Ac Immune S.A. | Safe and functional humanized antibodies |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| GB201315321D0 (en)* | 2013-08-28 | 2013-10-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Transduction Buffer |
| JP2025514328A (en) | 2022-04-28 | 2025-05-02 | アルツェオン・インコーポレーテッド | Tramiprosate for treating APOE4-related diseases |
| CN120641092A (en) | 2022-12-02 | 2025-09-12 | 阿尔泽恩股份有限公司 | Methods for treating neurodegenerative disorders with tramipsate |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en)* | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| CA2159326C (en)* | 1993-03-29 | 2000-05-30 | Robert Kisilevsky | Method for treating amyloidosis |
| EP1014994A1 (en)* | 1997-08-18 | 2000-07-05 | Queen's University At Kingston | Phosphono-carboxylate compounds for treating amyloidosis |
| AU2437899A (en)* | 1998-02-11 | 1999-08-30 | Neurochem, Inc. | Method for modulating macrophage activation |
| Publication number | Publication date |
|---|---|
| WO1999059571A1 (en) | 1999-11-25 |
| JP2002515429A (en) | 2002-05-28 |
| AU3726299A (en) | 1999-12-06 |
| EP1077690A1 (en) | 2001-02-28 |
| CA2333203A1 (en) | 1999-11-25 |
| MXPA00011213A (en) | 2003-04-22 |
| Publication | Publication Date | Title |
|---|---|---|
| IL139688A0 (en) | Use of amyloid inhibitors for modulating neuronal cell death | |
| IL128662A0 (en) | Heterocyclic metalloprotease inhibitors | |
| IL128664A0 (en) | Heterocyclic metalloprotease inhibitors | |
| IL137540A0 (en) | Inhibitors of phospholipase a2 | |
| IL128080A0 (en) | Thiol sulfonamide metalloprotease inhibitors | |
| PL340727A1 (en) | Benzothiazolic inhibitors of proteinous thyrosinic kinase | |
| ZA959948B (en) | Matrix metalloprotease inhibitors | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| IL130851A0 (en) | Heterocyclic compounds and their use for inhibiting beta-amyloid peptide | |
| PL343529A1 (en) | Substituted pyrrolidine hydroxamate metalloprotease inhibitors | |
| AU2548699A (en) | Cell death inhibitors | |
| IL128665A0 (en) | Bidenatate metalloprotease inhibitors | |
| HUP0101300A3 (en) | Matrix metalloprotease inhibitors | |
| AU2003203927A1 (en) | Use of amyloid inhibitors for modulating neuronal cell death | |
| HK1033427A (en) | Use of amyloid inhibitors for modulating neuronal cell death | |
| AU1103699A (en) | Use of an inhibitor of the dephosphorylation of darpp-32 for treating schizophrenia | |
| IL115383A0 (en) | Methods of inhibiting endometrial mitoses | |
| EP1038021A4 (en) | Compounds and methods for the inhibition of protein-protein interactions | |
| AU5102900A (en) | Neuronal death inhibitors | |
| EP1135141A4 (en) | Phospholipase inhibitors for the treatment of cancer | |
| GB9821614D0 (en) | Plug seal for threaded closure | |
| AU1511100A (en) | Methods for identifying modulators of neuronal growth | |
| AU2001286744A1 (en) | Compounds and methods for inhibiting neuronal cell death | |
| GB9415619D0 (en) | Metalloprotease inhibitors | |
| HK1020954A (en) | Heterocyclic metalloprotease inhibitors |